# Mira Pharmaceuticals, Inc.: filings

MIRA · Nasdaq · CIK 1904286 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/mira.md) · [Financials](/companies/mira/financials.md) · [Filings](/companies/mira/filings.md) · [Insiders](/companies/mira/insiders.md)

## Reports and events: 102 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 73, 4 34, 3 20, 10-Q 10, CORRESP 7, S-1/A 5, UPLOAD 5, 10-K 3, 424B5 3, EFFECT 3, SC 13D/A 3, 10-K/A 2, 144 2, 424B3 2, D 2, DEF 14A 2, DEFA14A 2, DRS/A 2, S-1 2, 10-Q/A 1, 144/A 1, 424B1 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, DEFM14A 1, DRS 1, DRSLTR 1, PREM14A 1, PRER14A 1, S-3 1, S-8 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 12:00 ET | [8-K](/filings/0001493152-26-048022.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048022 |
| 2026-09-17 | 12:30 ET | [8-K](/filings/0001493152-26-043051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043051 |
| 2026-09-16 | 20:30 ET | [8-K](/filings/0001493152-26-042927.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-042927 |
| 2026-09-01 | 12:00 ET | [8-K](/filings/0001493152-26-040930.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040930 |
| 2026-08-12 | 20:17 ET | [10-Q](/filings/0001493152-26-037366.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037366 |
| 2026-08-06 | 12:00 ET | [8-K](/filings/0001493152-26-036262.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036262 |
| 2026-07-31 | 21:00 ET | [8-K](/filings/0001493152-26-035665.md) | 3.01 Delisting notice | 0001493152-26-035665 |
| 2026-07-28 | 21:00 ET | [DEF 14A](/filings/0001493152-26-035027.md) | Proxy statement, period 2026-07-28 | 0001493152-26-035027 |
| 2026-07-10 | 12:00 ET | [8-K](/filings/0001493152-26-032777.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032777 |
| 2026-07-06 | 13:00 ET | [8-K](/filings/0001493152-26-032091.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032091 |
| 2026-06-25 | 12:00 ET | [8-K](/filings/0001493152-26-030033.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030033 |
| 2026-06-17 | 12:00 ET | [8-K](/filings/0001493152-26-028992.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028992 |
| 2026-06-08 | 21:00 ET | [8-K](/filings/0001493152-26-027751.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027751 |
| 2026-06-04 | 12:00 ET | [8-K](/filings/0001493152-26-027202.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027202 |
| 2026-05-27 | 12:00 ET | [8-K](/filings/0001493152-26-025335.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-025335 |
| 2026-05-14 | 19:03 ET | [10-Q](/filings/0001493152-26-023005.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023005 |
| 2026-05-13 | 20:01 ET | [8-K](/filings/0001493152-26-022704.md) | 7.01 Regulation FD disclosure | 0001493152-26-022704 |
| 2026-05-13 | 11:30 ET | [8-K](/filings/0001493152-26-022608.md) | 8.01 Other events | 0001493152-26-022608 |
| 2026-03-31 | 18:02 ET | [10-K](/filings/0001493152-26-014001.md) | Annual report, period 2025-12-31 | 0001493152-26-014001 |
| 2026-03-23 | 13:00 ET | [8-K](/filings/0001493152-26-012085.md) | 8.01 Other events | 0001493152-26-012085 |
| 2026-03-03 | 21:01 ET | [8-K](/filings/0001493152-26-008707.md) | 8.01 Other events | 0001493152-26-008707 |
| 2026-02-02 | 21:01 ET | [8-K](/filings/0001493152-26-004739.md) | 8.01 Other events | 0001493152-26-004739 |
| 2025-12-22 | 01:00 ET | [8-K](/filings/0001493152-25-028619.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-028619 |
| 2025-12-05 | 22:15 ET | [8-K](/filings/0001493152-25-026445.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-026445 |
| 2025-11-13 | 12:31 ET | [10-Q](/filings/0001493152-25-022112.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022112 |
| 2025-10-23 | 20:01 ET | [8-K](/filings/0001493152-25-019065.md) | 8.01 Other events | 0001493152-25-019065 |
| 2025-10-16 | 20:01 ET | [8-K](/filings/0001493152-25-018303.md) | 8.01 Other events | 0001493152-25-018303 |
| 2025-10-15 | 20:01 ET | [8-K](/filings/0001493152-25-018141.md) | 8.01 Other events | 0001493152-25-018141 |
| 2025-09-30 | 11:00 ET | [8-K](/filings/0001493152-25-016168.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-016168 |
| 2025-09-22 | 11:30 ET | [8-K](/filings/0001493152-25-014393.md) | 8.01 Other events | 0001493152-25-014393 |
| 2025-09-15 | 20:02 ET | [8-K](/filings/0001493152-25-013459.md) | 8.01 Other events | 0001493152-25-013459 |
| 2025-09-11 | 21:25 ET | [8-K](/filings/0001493152-25-013100.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013100 |
| 2025-08-19 | 12:00 ET | [8-K](/filings/0001641172-25-024731.md) | 8.01 Other events | 0001641172-25-024731 |
| 2025-08-14 | 20:31 ET | [10-Q](/filings/0001641172-25-024077.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024077 |
| 2025-08-12 | 12:00 ET | [8-K](/filings/0001641172-25-023110.md) | 8.01 Other events | 0001641172-25-023110 |
| 2025-07-29 | 20:01 ET | [8-K](/filings/0001641172-25-021356.md) | 8.01 Other events | 0001641172-25-021356 |
| 2025-07-28 | 20:01 ET | [8-K](/filings/0001641172-25-021155.md) | 8.01 Other events | 0001641172-25-021155 |
| 2025-07-10 | 20:19 ET | [8-K](/filings/0001641172-25-018595.md) | 8.01 Other events | 0001641172-25-018595 |
| 2025-07-08 | 21:25 ET | [8-K](/filings/0001641172-25-018247.md) | 8.01 Other events | 0001641172-25-018247 |
| 2025-07-02 | 20:06 ET | [8-K](/filings/0001641172-25-017557.md) | 8.01 Other events | 0001641172-25-017557 |
| 2025-06-30 | 11:30 ET | [8-K](/filings/0001641172-25-017046.md) | 8.01 Other events | 0001641172-25-017046 |
| 2025-06-24 | 20:01 ET | [8-K](/filings/0001641172-25-016285.md) | 8.01 Other events | 0001641172-25-016285 |
| 2025-06-17 | 20:01 ET | [8-K](/filings/0001641172-25-015401.md) | 8.01 Other events | 0001641172-25-015401 |
| 2025-05-28 | 12:00 ET | [8-K](/filings/0001641172-25-012603.md) | 8.01 Other events | 0001641172-25-012603 |
| 2025-05-21 | 21:25 ET | [8-K](/filings/0001641172-25-011936.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-011936 |
| 2025-05-14 | 20:30 ET | [10-Q](/filings/0001641172-25-010301.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010301 |
| 2025-05-08 | 11:30 ET | [8-K](/filings/0001641172-25-009155.md) | 8.01 Other events | 0001641172-25-009155 |
| 2025-05-06 | 11:30 ET | [8-K](/filings/0001641172-25-008748.md) | 8.01 Other events | 0001641172-25-008748 |
| 2025-04-23 | 11:30 ET | [8-K](/filings/0001641172-25-005772.md) | 8.01 Other events | 0001641172-25-005772 |
| 2025-04-17 | 21:28 ET | [10-K/A](/filings/0001641172-25-005313.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-005313 |

Page 1 of 3. [Older](/companies/mira/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.
